ACADIA Pharmaceuticals

Yahoo Finance • 21 days ago

Investment Manager Bets Big on PTCT Stock, Adds 41,000 Shares, According to Recent SEC Filing

Palo Alto Investors LP reported a buy of 41,303 shares of PTC Therapeutics(NASDAQ:PTCT) in its February 17, 2026, SEC filing, with an estimated transaction value of $3.00 million based on quarterly average pricing. What Happened Accordin... Full story

Yahoo Finance • 22 days ago

Investment Firm Adds Nearly $4 Milllion Worth of DYN Shares, According to Recent SEC Filing

Key Points 209,523-share increase in Dyne Therapeutics; estimated transaction value $3.97 million (based on quarterly average pricing) Quarter-end position in Dyne Therapeutics rose $12.82 million in value, reflecting both trading and sto... Full story

Yahoo Finance • 2 months ago

Acadia Faces EMA Setback On Rett Drug As Regulatory Test Looms

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Acadia Pharmaceuticals (NasdaqGS:ACAD) received a negative trend vote from the European Medicines Agency's Committee f... Full story

Yahoo Finance • 3 months ago

Acadia Pharmaceuticals to Present at the 44th Annual J.P. Morgan Healthcare Conference on January 13, 2026

SAN DIEGO, December 18, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that it will present at the 44th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Catherine Owen Adams, Chief Executive... Full story

Yahoo Finance • 4 months ago

David Einhorn's DME Capital takes stakes in PG&E, exits Teck Resources, among Q3 moves

[business man computer hand holding laptop tablet graph business stock market graph trading analysis investment financial stock exchange graph chart trader stock market analyzing digital technology] panida wijitpanya David Einhorn's DME C... Full story

Yahoo Finance • 6 months ago

Acadia Healthcare Appoints Todd Young as Chief Financial Officer

Young Brings 25 Years of Financial and Healthcare Industry Experience FRANKLIN, Tenn., October 07, 2025--(BUSINESS WIRE)--Acadia Healthcare Company, Inc. (NASDAQ: ACHC) ("Acadia" or the "Company") today announced the appointment of Todd Y... Full story

Yahoo Finance • 6 months ago

Stocks Retreat on Higher Bond Yields

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) on Wednesday closed down -0.28%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.... Full story

Yahoo Finance • 6 months ago

Stocks Pressured as Bond Yields Rise

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is down -0.03%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures... Full story

Yahoo Finance • 6 months ago

Stocks See Support from Strength in Chip Makers and AI Optimism

The S&P 500 Index ($SPX [https://www.barchart.com/futures/quotes/$SPX/overview]) (SPY [https://www.barchart.com/etfs-funds/quotes/SPY/overview]) today is up +0.06%, the Dow Jones Industrials Index ($DOWI [https://www.barchart.com/futures/q... Full story

Yahoo Finance • 6 months ago

Lithium Americas, Oracle, Acadia Pharma: Trending Tickers

Morning Brief host Julie Hyman tracks several of the day's top trending stock tickers, including reports that the Trump administration is pursuing a stake in miner Lithium Americas (LAC), Oracle's (ORCL) goal of raising $15 billion in bond... Full story

Yahoo Finance • 6 months ago

US High Growth Tech Stocks to Watch for Potential Expansion

As the United States stock market continues to reach new heights, with major indices like the S&P 500 and Nasdaq Composite posting consecutive weeks of gains, investors are paying close attention to high-growth sectors such as technology.... Full story

Yahoo Finance • 6 months ago

ACADIA Pharmaceuticals Inc. (ACAD) Nears Key Phase 3 Readout in Prader-Willi Syndrome

In this article, we will be taking a look at the 11 Best Performing Biotech Stocks So Far in 2025. ACADIA Pharmaceuticals Inc. stands second among them. ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD) is a biopharmaceutical company that focuses... Full story

Yahoo Finance • 6 months ago

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) Emerges as a Top Affordable Growth Stock

In the search for growth stocks that do not have high price tags, many investors use the "Affordable Growth" method. This method looks for firms showing good expansion numbers while keeping fair prices, good earnings, and sound finances, e... Full story

Yahoo Finance • 7 months ago

US High Growth Tech Stocks to Watch This August 2025

As of August 2025, the U.S. stock market is experiencing a remarkable upswing, with key indices like the S&P 500 and Dow Jones Industrial Average reaching record highs amid anticipation of a significant inflation report. In this thriving e... Full story

Yahoo Finance • 7 months ago

How Investors May Respond To ACADIA Pharmaceuticals (ACAD) Hiring an Industry Veteran for Growth Strategy

On August 25, 2025, Acadia Pharmaceuticals announced the appointment of Konstantina (“Tina”) Katcheves as Senior Vice President, Chief Business and Strategy Officer, bringing her extensive leadership experience from Teva Pharmaceuticals an... Full story

Yahoo Finance • 7 months ago

Acadia Pharmaceuticals Appoints Konstantina Katcheves as Senior Vice President, Chief Business and Strategy Officer

SAN DIEGO, August 25, 2025--(BUSINESS WIRE)--Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced the appointment of Konstantina ("Tina") Katcheves as Senior Vice President, Chief Business and Strategy Officer. In this role, Tina wil... Full story

Yahoo Finance • 7 months ago

Acadia Pharma EVP Schneyer sells $554k in stock

Acadia Pharmaceuticals (NASDAQ:ACAD), a $4.2 billion market cap company that has delivered an impressive 58% return over the past year, reported that Executive Vice President and Chief Financial Officer Mark C. Schneyer sold 22,000 shares... Full story

Yahoo Finance • 7 months ago

ACADIA PHARMACEUTICALS INC (NASDAQ:ACAD) Combines Strong Fundamentals with Bullish Technicals for Growth Potential

Combining solid fundamental growth with positive technical patterns can be an effective way to spot stocks with potential gains. This method looks for companies that show increasing revenue and earnings growth while also displaying positiv... Full story

Yahoo Finance • 7 months ago

High Growth Tech Stocks To Watch In The US August 2025

As the U.S. market experiences a mix of record highs and tempered expectations due to recent inflation reports, investors are closely monitoring economic indicators that could influence Federal Reserve policy decisions on interest rates. I... Full story

Yahoo Finance • 8 months ago

Acadia raises 2025 NUPLAZID guidance to $665M–$690M as DAYBUE accelerates community uptake

Earnings Call Insights: ACADIA Pharmaceuticals (ACAD) Q2 2025 MANAGEMENT VIEW * Catherine E. Owen Adams, CEO, stated that "Our second quarter performance reinforces the momentum we're building across all facets of our business from com... Full story